A levels impede reprogramming. Our results therefore uncover a role for miRNAs in regulating m 6 A formation of mRNAs and provide a foundation for future functional studies of m 6 A modification in cell reprogramming.
INTRODUCTION
More than 100 types of post-transcriptional modifications have been identified in RNAs so far (Cantara et al., 2011; Globisch et al., 2011; He, 2010) , among which N 6 -methyladenosine (m 6 A) RNA methylation is one of the most prevalent modifications of messenger RNAs (mRNAs) (Desrosiers et al., 1974; Wei et al., 1975) . m 6 A accounts for about 50% of total methylated ribonucleotides and is present in 0.1%-0.4% of all adenosines in total cellular RNAs (Desrosiers et al., 1974; Wei et al., 1975) . In vivo, the formation of m A is catalyzed by a multicomponent methyltransferase complex with at least three proteins, namely methyltransferase-like 3 (METTL3), METTL14, and Wilms' tumor 1-associating protein (WTAP) (Bokar et al., 1997; Finkel and Groner, 1983; Ping et al., 2014; Schwartz et al., 2014; Wang et al., 2014b) . The m 6 A modification can be removed by RNA demethylases, of which the two known ones are fat mass and obesity-associated protein (FTO) and alkylated DNA repair protein alkB homolog 5 (ALKBH5) (Jia et al., 2011; Zheng et al., 2013) . So far, two YTH (YT521-B homology)-domain containing proteins, YTHDF2 and YTHDC1, have been identified to specifically recognize m 6 A-modified RNAs (Dominissini et al., 2012; Xu et al., 2014; Zhu et al., 2014) . In general, m 6 A modification can be detected in the mRNAs of over 7,000 genes in mammalian cells, and it tends to occur at the consensus RRACH motif (R = G or A; H = A, C, or U) (Bodi et al., 2010; Dominissini et al., 2012; Harper et al., 1990; Meyer et al., 2012; Wei and Moss, 1977) . On average, the frequency of m 6 A modification is about one peak per 2,000 nucleotides (nts), but there are also some regions with clustered m 6 A peaks (Dominissini et al., 2012; Kane and Beemon, 1985; Meyer et al., 2012) . Strong enrichment of m 6 A modification has been found near the stop codons of mRNAs (Dominissini et al., 2012; Meyer et al., 2012) . Although the existence of m 6 A does not change the coding capacity or base pairing of adenine with uracil or thymine, it may block the nonstandard A:G base pairing and influence RNA structures (Dai et al., 2007) . The presence of m 6 A may also affect the expression level, translation efficiency, nuclear retention, splicing, and stability of mRNAs (Camper et al., 1984; Finkel and Groner, 1983; Fustin et al., 2013; He, 2010; Hess et al., 2013; Ping et al., 2014; Schwartz et al., 2013; Tuck et al., 1999; Wang et al., 2014a Wang et al., , 2014b Zhao et al., 2014; Zheng et al., 2013) . Deficiency of m 6 A formation has been proven to affect circadian rhythm, cell meiosis, and embryonic stem cell (ESC) proliferation, and thus it is implicated in obesity, cancer, and other human diseases (Batista et al., 2014; Dominissini et al., 2012; Geula et al., 2015; He, 2010; Liu et al., 2013; Machnicka et al., 2013; Meyer et al., 2012; Niu et al., 2013; Sibbritt et al., 2013) . However, the regulatory mechanisms of m 6 A formation and the function of m 6 A in regulating cell reprogramming are still largely unknown.
Here we examined the transcriptome-wide distribution of m 6 A modification in mouse ESCs, induced pluripotent stem cells (iPSCs), neural stem cells (NSCs), and testicular sertoli cells (SCs). Our results identified the difference in m 6 A distribution between pluripotent and differentiated cell types. We discovered that the m 6 A formation of mRNAs is regulated by microRNAs (miRNAs) via a sequence pairing mechanism, and we revealed m 6 A as a positive regulator for cell reprogramming to pluripotency.
RESULTS

General Features of m 6
A Distribution in Mouse Pluripotent and Differentiated Cell Lines To investigate the features and distribution dynamics of mRNA m 6 A modification in different cell types, we performed m 6 Aseq using mouse ESCs, iPSCs, NSCs, and SCs. In total, 33,000-43,000 m 6 A-enriched regions, also known as m 6 A peaks, were identified on mRNAs of 7,000-8,000 expressed genes in each cell type. Using m 6 A-qRT-PCR, 13 out of 15 randomly selected m 6 A peaks were verified in all cell types (Fig- ures S1A and S1B), implying a high authenticity of our data. Genes encoding transcripts with m 6 A modifications involved in many essential biological processes, including transcription regulation, chromatin modification, cell cycle control, apoptosis, etc., among which transcripts encoding proteins for DNA binding activity were identified as the most significantly enriched group (counted for over 10% of m 6 A-modified genes) ( Figure S1C , Table S1, and Table S2 ). Similar to previous reports (Dominissini et al., 2012; Meyer et al., 2012) , we also observed a tendency toward m 6 A distribution in the coding sequence (CDS) region of mRNAs, with a strong enrichment around the translation termination sites (TsTS) in all four examined cell types ( Figure S1D ). Transcripts of majority genes (ESCs, 77%; iPSCs, 72%; NSCs, 63%; SCs, 74%) each harbored fewer than five m 6 A peaks, yet there were transcripts of some genes (ESCs, 9%; iPSCs, 4%; NSCs, 12%; SCs, 6%) with over 50% of their lengths covered by m 6 A peaks ( Figure S1E ); we thus named these ''m 6 A high-coverage transcripts.'' The length of these m 6 A high-coverage transcripts did not differ significantly from that of the overall transcripts, and some of these transcripts encoded proteins involved in the regulation of processes essential for the maintenance of cell-type specific features, such as neuron differentiation and development in NSCs (Table S3) . A Modification Using the Shannon-entropy-based method (Xie et al., 2013) , we identified a total of 8,558 genes with stable expression in all examined cell types (Table S4) . Among them, only transcripts of 3,880 genes had m 6 A modifications in all samples and were enriched in essential biological processes ( Figure 1A and Table S4 ). On the other hand, transcripts of 1,087 stably expressed genes had no m 6 A modification in any examined cell type, and the functions of these genes tended to relate to the synthesis and functional establishment of proteins ( Figure 1B and Table S4 Figure 1C ), and the rest of the transcripts (3,443; 89% of 3,880) had variable m 6 A peaks in at least two cell types ( Figure 1D ). A total of 1,695 genes were identified as cell-type-specifically expressed, of which 998 genes had transcripts with m 6 A modifications ( Figure 1E and Table S5 ). In addition, among the 8,558 genes with stable expression in all cell types, the transcripts of 877 genes had cell-type-specific m 6 A modifications. Gene ontology analysis revealed transcripts with celltype-specific m 6 A modifications involved in many cell-typespecific biological processes, such as stem cell maintenance and developmental regulation in ESCs and iPSCs, as well as neuron differentiation and forebrain development regulation in NSCs (Table S5 ). As expected, many known cell-type specific markers were among these genes, including key transcription factors essential for specific features of each cell type, such as Oct4, Nanog, and DPPA2 for ESCs and iPSCs; POU3F2 and ROBO2 for NSCs; and DHH and Sox8 for SCs (Figures 1E and S1F) . More than 87% of identified m 6 A peaks contained the previously reported RRACH motif, with GGACU as the most frequent motif in all examined cell types ( Figure 2A ). The enrichment of the RRACH motif among m 6 A peaks was significantly higher than that among the control peaks (p < 2.2eÀ16, Fisher's exact test). In addition, we also identified a few other motifs (ESCs: 15; iPSCs: 9; NSCs: 8; SCs: 12) within 87%-99% of m 6 A peak regions ( Figures S2A-S2D ). Intriguingly, we found that the RRACH motif and over two-thirds (67%-89%, depending on the cell type) of the identified motifs were reversely complementary to the seed sequences (5 0 2-8 nucleotides) of one or more miRNAs with at most 1 nt mismatch, indicating that the m 6 A peak regions may be targeted by miRNAs . Further analysis revealed that 92%-96% of the m 6 A peaks could pair with miRNAs with relatively strict alignment criteria. In particular, the RRACH motif region of m 6 A peaks could potentially pair with 482 miRNAs. The enrichment of miRNA binding sites See also Figure S1 , Table S1 , Table S2, Table S3, Table S4 , Table S5 , and Table S6. among m 6 A enriched motifs was remarkably higher than those of the randomly simulated motifs ( Figure 2D ). To investigate whether these m 6 A-targeting miRNAs were indeed expressed in corresponding cells, we quantified miRNA expression using small RNA-seq in ESCs. Of the 1,866 m 6 Atargeting miRNAs, 818 were detected to be expressed in ESCs. These expressed miRNAs had a significant tendency to target m 6 A peaks as compared to control peaks (71% versus 39%, p < 2.2eÀ16, Fisher's exact test). The consistency between small RNA-seq data and cellular miRNA abundance was validated by qRT-PCR on 12 randomly selected miRNAs (including 2 cell-type-specific ones) (Figures S2E and S2F) . Using the same criteria, 75% of m 6 A peaks were identified as potential targets of expressed miRNAs in HeLa cells using the published m 6 A data (Wang et al., 2014a) , indicating the conservation of miRNA regulation on m 6 A between human and mouse.
Formation of m 6
A Depends on Dicer, but Not Argonaute To investigate whether miRNAs were indeed involved in the regulation of m 6 A, we examined the effects of key miRNA biogenesis proteins on cellular m 6 A abundance. Knocking down Dicer, the endonuclease responsible for producing mature miRNAs, significantly reduced cellular m 6 A abundance in both mouse NSCs (Figures 3A and 3B and S3A) and human HeLa cells (Figures 3D and 3E and S3B) . Conversely, overexpressing Dicer increased the m 6 A modification level ( Figures 3G, 3H , 3J, 3K, and S3C). In all these experiments, expected Dicer and miRNA expression changes were detected, whereas the protein abundance of neither m 6 A methyltransferase METTL3 nor demethylases FTO and ALKBH5 were affected ( Figures 3C, 3F , 3I, 3L, and S3D), suggesting that Dicer-induced m 6 A abundance change was not achieved by the alteration of the quantity of m 6 A methyltransferase or demethylases in cells.
Argonaute (AGO) proteins are the key components of known miRNA functional pathways and mediate the binding of miRNAs to their target mRNAs (Bartel, 2004; Cenik and Zamore, 2011; Meister, 2013; Rand et al., 2005) . We further examined whether AGO proteins participate in the regulation of m 6 A formation. The genomes of human and mouse each encode four types of AGO clade proteins (AGO1-AGO4) with miRNA binding ability (Cenik and Zamore, 2011; Meister, 2013) . Unexpectedly, knocking down individual AGO expression in HeLa cells had no effect on m 6 A abundance ( Figures S3E-S3G ). To avoid functional redundancy, we further used mixed siRNAs to knock down all four AGO genes in mouse NSCs and human HeLa cells. Neither To investigate whether miRNAs are capable of mediating the ab initio formation of m 6 A, we mutated three nucleotides in the 5 0 2-8 nt region (seed sequence of miRNAs) of four miRNAs, namely miR-330-5p, miR-668-3p, miR-1224-5p, and miR-1981-5p, to make the mutated miRNAs pairing with mRNA regions originally without m 6 A peaks. Consistent results from six individual loci in mouse NSCs demonstrated that overexpression of the mutated miRNAs indeed caused the formation of m 6 A at the designed target sites, whereas regions not targeted by the mutated miRNAs had no m 6 A abundance change (control: KIF1B and control:SCD2) ( Figures 4D and S4J ). Due to the mutations, some m 6 A peaks originally targeted by endogenous miRNAs were no longer targeted by the mutated ones, and no m 6 A abundance change was detected at these sites either (i.e., control:SSRP1 was targeted by miR-1224-5p, but not its mutant) (Figures 4D and S4J ). These results demonstrated that miRNAs are capable of inducing de novo m 6 A methylation via a sequence-dependent manner.
miRNAs Modulate METTL3 Binding to mRNAs The ab initio induction of m 6 A methylation by mutated miRNAs drove us to speculate that miRNAs may regulate the interaction between METTL3 and mRNAs. To test this hypothesis, we first examined whether modulating Dicer expression could affect the subcellular localization of METTL3, as it has been shown that METTL3 locates and functions at nuclear speckles Ping et al., 2014; Wang et al., 2014b) . Knocking down Dicer significantly reduced the nuclear staining density of METTL3 in human HeLa cells (Figures 5A and 5B) . Further examination using ASF (a nuclear speckle marker) staining revealed that the nuclear speckle localization of METTL3 was indeed disrupted in Dicer knockdown HeLa cells ( Figure 5C ), whereas the METTL3 abundance in both nucleus and cytoplasm almost remained unchanged ( Figures 5D and S5A ). Co-immunoprecipitation assay revealed that Dicer did not associate with METTL3 ( Figures S5B and S5C ), ruling out a potential physical interaction between METTL3 and Dicer. Taken together, these results indicated that Dicer regulates the nuclear speckle localization of METTL3.
We next performed Photoactivatable-RibonucleosideEnhanced Crosslinking and Immunoprecipitation (PAR-CLIP) to examine the amount of RNA associated with METTL3. Intriguingly, upon Dicer depletion, the amount of RNA crosslinked to Myc-tagged METTL3 was significantly reduced in human HeLa cells ( Figures 5E and 5F ). To further investigate whether the binding of METTL3 on mRNAs could be altered by individual miRNAs processed by Dicer, we performed an RNA immunoprecipitation (RIP) assay with METTL3 antibody to precipitate endogenous METTL3 and its associated mRNAs from HeLa cells, after the overexpression of miR-423-3p and miR-1226-3p or their antagomirs. In concert with the results of Dicer manipulation, overexpressing miRNAs significantly increased the amount of mRNAs associated with METTL3, whereas downregulating miRNA abundance by antagomirs significantly reduced METTL3 binding on mRNAs (i.e., DGCR2 and TUBB4B, targeted by miR-423-3p and miR-1226-3p, respectively) in HeLa cells (Figures 5G and 5H) . Consistently, the amounts of METTL3-crosslinked total RNAs ( Figure 5I ) and mRNAs (i.e., TCF4 and RPS13) targeted by designed miRNAs (Figures 5J and S5D) were also altered in mouse NSCs when manipulating Dicer or corresponding miRNAs, respectively. In both the mouse and human experiments, the abundance of METTL3-bound mRNAs not targeted by the designed miRNAs was not altered (i.e. TXNRD1 and CTNNA1 in Figure 5G ; EEF1A1 in Figure 5J ). Collectively, these results showed that miRNAs regulate the m 6 A methyltransferase activity of METTL3 by modulating its binding to mRNAs. Values and error bars in all bar plots represent the mean and standard deviation (SD) of three independent experiments. **p < 0.01 and ***p < 0.001 by Student's t test. See also Figure S3 and Table S6 . 6B ). Enhanced expression of key pluripotent factors, such as Oct4, Sox2, and Nanog, was also observed in METTL3-overexpressing cells ( Figure 6C ). Conversely, inhibiting m 6 A formation by knocking down METTL3 expression using siRNAs during the reprogramming process resulted in reduced iPSC colony numbers as well as decreased pluripotent gene expression ( Figures 6D-6F , Figure S6A right panels, and Figure S6C ). Decreased m 6 A abundance and iPSC colony numbers were also observed with the addition of cycloleucine, a competitive inhibitor of methionine adenosyltransferase (Finkel and Groner, 1983) , during the reprogramming process ( Figures S6D-S6F ). Furthermore, overexpression of human Myc-METTL3 insensitive to mouse METTL3 siRNAs in mouse METTL3 knockdown MEFs successfully rescued the reprogramming efficiency ( Figures 6D-6F , Figure S6A right panels, and Figure S6C ). These data indicated that m 6 A is required for MEF reprogramming to pluripotency and can promote the reprogramming efficiency.
DISCUSSION
Increasing lines of evidence have shown that m 6
A modification may play pivotal physiological functions in regulating RNA metabolism and various biological processes (Bodi et al., 2012; Bokar, 2005; Fustin et al., 2013; Geula et al., 2015; Jia et al., 2011; Ping et al., 2014; Schwartz et al., 2013; Wang et al., 2014a Wang et al., , 2014b Zhao et al., 2014; Zheng et al., 2013; Zhong et al., 2008) . With the advances of m 6 Aseq technology, the basic features of m 6 A modification have been characterized in some tissues and cell lines of mouse and human (Batista et al., 2014; Dominissini et al., 2012; Fustin et al., 2013; Meyer et al., 2012; Schwartz et al., 2013; Wang et al., 2014b ). Yet the dynamics of m 6 A among different cell types and its regulatory mechanisms are still largely unknown.
Here we reported cross cell-type comparison of m 6 A profiles using mouse pluripotent and differentiated cell lines. We identified transcripts with cell-type-dependent common or specific m 6 A modifications and revealed the dynamic changes of m 6 A across cell types on some consistently expressed transcripts. These results will provide clues for further functional studies of m 6 A modification.
miRNAs are a group of important post-transcriptional regulators in eukaryotes. Two previous reports discussed that the presence of m 6 A may affect the binding of miRNAs to target mRNAs (Meyer et al., 2012; Wang et al., 2014b) , but whether miRNAs have direct regulatory roles in the formation of m 6 A has not been explored yet. Here, we showed that the overall cellular m 6 A abundance and m 6 A on individual mRNAs can be altered by the modulation of the expression of the miRNA biogenesis enzyme Dicer or miRNAs. In addition, overexpression of miRNA mutants creates m 6 A methylation ab initio on originally unmethylated mRNA sequences via a sequencedependent mechanism. We have further found that the function of miRNAs in regulating m 6 A is achieved by the mediation of the binding of m 6 A methyltransferase METTL3 to mRNAs. These results reveal the functions of miRNAs in regulating the formation of m 6 A, and they also partially explain the site selection mechanism of m 6 A.
As the key effector proteins of the miRNA functional cascade, AGO proteins have been shown to bind to miRNAs and help miRNAs to execute their functions. However, our results showed that in both human and mouse cells, none of the AGO1-AGO4 proteins were involved in miRNA-mediated m A modification in cell fate determination are still largely unknown so far. By examining the functions of m 6 A in regulating cell reprogramming using the iPSC technology, we have revealed a positive role of m 6 A in regulating cell reprogramming. Such effects were accompanied by altered expression of key pluripotent factors, such as Oct4, Sox2, and Nanog. Consistently, two recent studies reported that proper formation of m 6 A is required for maintaining the ground state of human and mouse ESCs (Batista et al., 2014; Geula et al., 2015) , which is in concert with the function of m 6 A in promoting the iPSC process identified in this work. All these suggested that proper m 6 A formation is essential for differentiated cells to regain pluripotent property. In summary, our study provided the m 6 A profiles in mouse pluripotent and differentiated cell lines and identified the celltype-specific and several other features of m 6 A modification.
We have demonstrated that miRNAs are involved in the Values and error bars in all bar plots represent the mean and SD of three independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001 by Student's t test. See also Figure S4 and Table S6 . A may serve as a strategy to regulate cell reprogramming.
EXPERIMENTAL PROCEDURES Generation of iPSCs and Reprogramming Efficiency Evaluation
Generation of pluripotent iPSC lines was performed as described previously (Wernig et al., 2008) . MEFs were isolated from E13.5 embryos heterozygous for the Oct4::GFP transgenic allele, as previously described (Huangfu et al., 2008) , and cultured under established iPSC conditions with the four Yamanaka factors (Oct4, Sox2, Klf4, expressed. The efficiency of iPSC formation is estimated according to the number of Oct4-GFP-positive colonies. GFP-positive colonies after 15 days of reprogramming were trypsinized and then analyzed using a FACS Calibur (BD Biosciences). A minimum of 10,000 events were recorded. Detection of alkaline phosphatase, which is an indicator of undifferentiated ESCs, was carried out after 15 days of reprogramming. The number of iPSC colonies per well was counted in triplicates. The expression of key pluripotent factors Oct4, Sox2, and Nanog was detected by qRT-PCR. A immunoprecipitation and library construction procedure were modified from published procedure (Meyer et al., 2012) . In brief, fragmented and ethanol precipitated mRNA (3 mg) from different cell lines was incubated with 5 mg of anti-m 6 A polyclonal antibody (Synaptic Systems, 202003) in IPP buffer (150 mM NaCl, 0.1% NP-40, and 10 mM Tris-HCl [pH 7.4]) for 2 hr at 4 C.
The mixture was then immunoprecipitated by incubation with 50 ml protein-A beads (Sigma, P9424) at 4 C for an additional 2 hr. After being washed three times, bound RNA was eluted from the beads with 0.5 mg/ml N 6 -methyladenosine (BERRY & ASSOCIATES, PR3732) in IPP buffer and then extracted by Trizol. The remaining RNA was re-suspended in H 2 O and used for library generation with mRNA sequencing kit (Illumina). Sequencing was carried out using the RNA-seq method as described in the Supplemental Procedures.
Sequencing Data Processing and m 6 A Peak Calling
Sequence reads were mapped to the mouse reference genome (mm9) using TopHat (version 2.0.4) with a RefSeq-based transcript index (Kim et al., 2013) . For RNA-seq analysis, the expression of transcripts was quantified as Fragments Per Kilobase of transcript per Million mapped reads (FPKM) and estimated by Cufflinks (version 2.0.2) . Cell-type-specific transcripts were identified using the Shannon entropy of each transcript following the previously reported method (Xie et al., 2013) . To identify m ples of the same loci with a method modified from a previous report (Meyer et al., 2012) . Briefly, the entire mouse genome was divided into 25 nt bins and the numbers of both m 6 A-seq reads and RNA-seq reads (used as control) A peaks were identified by HOMER with m 6 A peaks as the target sequences and control peaks as the background using default parameters (Heinz et al., 2010) and visualized using WebLogo (Crooks et al., 2004) . The enriched motifs were randomly shuffled to generate 500 groups of simulated motifs in each cell type and were used for specificity analysis.
Relationship Analysis of miRNAs with m 6 A Peaks Mouse mature miRNA sequences were downloaded from miRBase (Release 20 with 1,908 mouse miRNA sequences) (Kozomara and Griffiths-Jones, 2011) , then compared with the motifs identified by HOMER or randomly simulated motifs using in-house scripts. miRNAs with seed regions (5 0 2-8 nts)
reverse complementarily pairing (with at most one mismatch) to m 6 A motifs were selected. To compare miRNA sequences with all m 6 A peaks, the entire sequences of identified m 6 A peaks and control peaks were extracted and paired with the miRNA sequences using miRanda software with ''Àsc 155 Àen À20'' and other default settings as parameters (Enright et al., 2003) . m 6 A peak sequences and control peak sequences that passed the above criteria were identified as miRNA-targeted peaks. Under the iPSC induction condition as described above, the following experiments were carried out from the first day of reprogramming. In the METTL3 overexpression experiments, 5 mg of plasmids expressing pCMV-Myc-METTL3 and 5 mg pCMV-Myc-control plasmids were transfected into MEFs using Lipofectamine 2000 kit (Invitrogen) three times every 3 days. In the METTL3 knockdown experiment, 75 nM siRNAs targeting METTL3 and 75 nM control siRNAs were transfected into MEFs using Lipofectamine RNAiMAX (Invitrogen) four times every 3 days. In the rescue experiment, 5 mg of plasmids expressing pCMV-Myc-hMETTL3 , which does not contain the target site of mouse METTL3 siRNAs, and 5 mg of control plasmids were transfected into the METTL3 knockdown MEFs three times every 3 days. In the chemical m 6 A inhibition experiments, 20 mM cycloleucine was added to the culture medium of MEFs once per day for 10 days.
Statistical Analysis
Student's t test was used for all statistical analyses for experimental results (unless stated otherwise). See Supplemental Experimental Procedures for a full description of the methods.
ACCESSION NUMBERS
Sequencing data generated by this work have been deposited into the Gene Expression Omnibus (GEO; accession number GSE52125). Values and error bars in all bar plots represent the mean and SD of three independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001 by Student's t test. See also Figure S5 and Table S6 . (E) AP-positive clones among reprogrammed MEFs with control siRNAs (si-Control), siRNAs for mouse METTL3 (si-mMETTL3), and human Myc-METTL3 rescue (si-mMETTL3+OE-hMETTL3).
(F) The expression levels (detected by qRT-PCR) of endogenous Oct4, Sox2, and Nanog in cells during the reprogramming process of MEFs with control siRNAs (si-Control), siRNAs for mouse METTL3 (si-mMETTL3), and human Myc-METTL3 rescue (si-mMETTL3+OE-hMETTL3). Values and error bars in all plots represent the mean and SD of three independent experiments. *p < 0.05 by Student's t test. See also Figure S6 and 
